These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4132274)

  • 1. Letter: G.A.B.A. and brain function and dysfunction.
    van den Berg CJ; Matheson DF
    Lancet; 1974 Apr; 1(7858):620. PubMed ID: 4132274
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: G.A.B.A. in Huntington's chorea.
    Fisher R; Norris JW; Gilka L
    Lancet; 1974 Jun; 1(7870):1347-8. PubMed ID: 4134677
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: G.A.B.A. and Huntington's chorea.
    Barbeau A
    Lancet; 1973 Dec; 2(7844):1499-500. PubMed ID: 4129342
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: Dopamine and G.A.B.A. in Huntington's chorea.
    Lancet; 1974 Nov; 2(7889):1122-3. PubMed ID: 4139415
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: G.A.B.A. in Huntington's chorea.
    Perry TL; Hansen S; Urquhart N
    Lancet; 1974 May; 1(7864):995-6. PubMed ID: 4133688
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple dopamine receptors: relevance for neurodegenerative disorders.
    Strange PG
    Biochem Soc Trans; 1994 Feb; 22(1):155-9. PubMed ID: 8206214
    [No Abstract]   [Full Text] [Related]  

  • 7. Huntington's chorea, lithium, and G.A.B.A.
    Mattsson B; Persson SA
    Lancet; 1973 Sep; 2(7830):684. PubMed ID: 4125664
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: G.A.D. and G.A.B.A.
    Lancet; 1974 Feb; 1(7852):298-300. PubMed ID: 4130480
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: G.A.B.A. in Huntington's chorea.
    Fisher R; Norris JW; Gilka L
    Lancet; 1974 Mar; 1(7856):506. PubMed ID: 4131904
    [No Abstract]   [Full Text] [Related]  

  • 10. Catecholamines and neurologic diseases (second of two parts).
    Moskowitz MA; Wurtman RJ
    N Engl J Med; 1975 Aug; 293(7):332-8. PubMed ID: 125386
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the use of phenothiazines in neurology].
    Soyka D
    Med Welt; 1967 Mar; 10():553-6. PubMed ID: 4231369
    [No Abstract]   [Full Text] [Related]  

  • 12. Disease targets and strategies for the therapeutic modulation of endogenous neural stem and progenitor cells.
    Goldman SA
    Clin Pharmacol Ther; 2007 Oct; 82(4):453-60. PubMed ID: 17713467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection.
    Vamos E; Pardutz A; Klivenyi P; Toldi J; Vecsei L
    J Neurol Sci; 2009 Aug; 283(1-2):21-7. PubMed ID: 19268309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involuntary movement disorders.
    Still CN
    Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of dietary vitamin B 6 deficiency on the development of the gamma-aminobutyrate shunt in rat brain.
    Bayoumi RA; Smith WR
    Biochem J; 1972 May; 127(5):84P-85P. PubMed ID: 5076231
    [No Abstract]   [Full Text] [Related]  

  • 16. [Progress in the treatment of degenerative diseases of the nervous system. Selected problems].
    Zaleska B
    Neurol Neurochir Pol; 1980; 14(2):209-12. PubMed ID: 6446688
    [No Abstract]   [Full Text] [Related]  

  • 17. Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington's, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease.
    Mori F; Tanji K; Toyoshima Y; Yoshida M; Kakita A; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2012 May; 123(5):747-9. PubMed ID: 22318854
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuropeptides in neurological disease.
    Beal MF; Martin JB
    Ann Neurol; 1986 Nov; 20(5):547-65. PubMed ID: 2947536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alpha- methyl-P-tyrosine effect in extrapyramidal diseases].
    Birkmayer W
    Wien Klin Wochenschr; 1969 Jan; 81(1):10-2. PubMed ID: 4237567
    [No Abstract]   [Full Text] [Related]  

  • 20. Parkinson's disease, Huntington's disease and tardive dyskinesia. Neurochemical pathology and treatment.
    Tolosa ES
    Minn Med; 1979 Feb; 62(2):101-6. PubMed ID: 155195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.